Niki BioSolutions, Inc. (NIKI) › Operating Cash FlowNiki BioSolutions, Inc. (NIKI) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$10.04M2019: -$13.38M2020: -$15.93M2021: -$14.65M2022: -$12.32M2023: -$7.72M2024: -$1.19M2025: -$1.84M-$1.84M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$1.84M-54.4%2024-$1.19M+84.6%2023-$7.72M+37.3%2022-$12.32M+15.9%2021-$14.65M+8.0%2020-$15.93M-19.0%2019-$13.38M-33.4%2018-$10.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share